Video

Dr. O'Regan on the Status of Biosimilars in Oncology

Ruth O’Regan, MD, division head, Hematology and Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, discusses the status of biosimilars in oncology.

Ruth O’Regan, MD, division head, Hematology and Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, discusses the status of biosimilars in oncology.

Biosimilars are beginning to take off in the field of oncology, explains O’Regan. Data on trastuzumab (Herceptin) biosimilars have been presented from randomized studies, demonstrating similar safety and immunogenicity profiles. Though these biosimilars may be ready for use in practice, says O’Regan, patients who have been on trastuzumab for years may not be comfortable making the switch to the biosimilar.

Nonetheless, biosimilars are an exciting breakthrough in oncology, and there are those in development outside of breast cancer, including those that physicians use as supportive agents, notes O’Regan. Additionally, different methods of administration are being explored, such as a subcutaneous injection. There is no doubt that biosimilars will have an impact on the field of oncology, says O’Regan, but the hope is that they will ultimately decrease the cost of cancer therapy.

Related Videos
Francine Foss, MD
Ami Umesh Badami, MD
Kenneth Shain, MD, PhD
Piotr Rutkowski, MD
Manali Kamdar, MD, of University of Colorado Anschutz School of Medicine
Janaki Neela Sharma, MD, assistant professor, clinical medicine, Genitourinary Medical Oncology, University of Miami Health Systems
Cindy Medina Pabon, MD, assistant professor, Sylvester Cancer Center, University of Miami; assistant lead, GI Cancer Clinical Research, Gastrointestinal Medical Oncology, University of Miami Health Systems
Jonathan Spicer, MD, PhD, FRCS
Daniel DeAngelo, MD, PhD
Marc J. Braunstein, MD, PhD, associate professor, Department of Medicine, co-director, Hematology-Oncology System, New York University (NYU) Grossman Long Island School of Medicine